［1］BARIK S.Molecular interactions between pathogens and the circadian clock ［J］.International Journal of Molecular Sciences,2019,20(23):5824.
［2］DIBNER C,SCHIBLER U,ALBRECHT U.The mammalian circadian timing system:organization and coordination of central and peripheral clocks ［J］.Annual Review of Physiology,2010,72(1):517-549.
［3］PARTCH CL,GREEN CB,TAKAHASHI JS.Molecular architecture of the mammalian circadian clock ［J］.Trends in Cell Biology,2014,24(2):90-99.
［4］YE R,SELBY CP,CHIOU YY,et al.Dual modes of CLOCK:BMAL1 inhibition mediated by cryptochrome and period proteins in the mammalian circadian clock ［J］.Genes Dev,2014,28(18):1989-1998.
［5］ALLADA R,BASS J.Circadian mechanisms in medicine ［J］.The New England Journal of Medicine,2021,384(6):550-561.
［6］GUILLAUMOND F,DARDENTE H,GIGUERE V,et al.Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors ［J］.Journal of Biological Rhythms,2005,20(5):391-403.
［7］ROENNEBERG T,MERROW M.The circadian clock and human health ［J］.Curr Biol,2016,26(10):R432-443.
［8］WEGRZYN LR,TAMIMI RM,ROSNER BA,et al.Rotating night-shift work and the risk of breast cancer in the nurses' health studies ［J］.Am J Epidemiol,2017,186(5):532-540.
［9］DICKERMAN BA,MARKT SC,KOSKENVUO M,et al.Sleep disruption,chronotype,shift work,and prostate cancer risk and mortality:a 30-year prospective cohort study of Finnish twins ［J］.Cancer Causes Control,2016,27(11):1361-1370.
［10］SCHERNHAMMER ES,LADEN F,SPEIZER FE,et al.Night-shift work and risk of colorectal cancer in the nurses' health study ［J］.J Natl Cancer Inst,2003,95(11):825-828.
［11］LESICKA M,JABLONSKA E,WIECZOREK E,et al.Altered circadian genes expression in breast cancer tissue according to the clinical characteristics ［J］.PloS One,2018,13(6):e0199622.
［12］HSU CM,LIN SF,LU CT,et al.Altered expression of circadian clock genes in head and neck squamous cell carcinoma ［J］.Tumour Biology,2012,33(1):149-155.
［13］OSHIMA T,TAKENOSHITA S,AKAIKE M,et al.Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer ［J］.Oncology Reports,2011,25(5):1439-1446.
［14］LEE Y,LAHENS N F,ZHANG S,et al.G1/S cell cycle regulators mediate effects of circadian dysregulation on tumor growth and provide targets for timed anticancer treatment ［J］.PLoS Biol,2019,17(4):e3000228.
［15］FILIPSKI E,KING VM,LI X,et al.Host circadian clock as a control point in tumor progression ［J］.J Natl Cancer Inst,2002,94(9):690-697.
［16］FU L,PELICANO H,LIU J,et al.The circadian gene period2 plays an important role in tumor suppression and DNA damage response in vivo ［J］.Cell,2002,111(1):41-50.
［17］MATSUO T,YAMAGUCHI S,MITSUI S,et al.Control mechanism of the circadian clock for timing of cell division in vivo ［J］.Science (New York,NY),2003,302(5643):255-259.
［18］HANAHAN D,WEINBERG RA.Hallmarks of cancer:the next generation ［J］.Cell,2011,144(5):646-674.
［19］MALUMBRES M,BARBACID M.Cell cycle,CDKs and cancer:a changing paradigm ［J］.Nature Reviews Cancer,2009,9(3):153-166.
［20］WANG Q,AO Y,YANG K,et al.Circadian clock gene Per2 plays an important role in cell proliferation,apoptosis and cell cycle progression in human oral squamous cell carcinoma ［J］.Oncology Reports,2016,35(6):3387-3394.
［21］YU Y,LI Y,ZHOU L,et al.Cryptochrome 2 (CRY2) suppresses proliferation and migration and regulates clock gene network in osteosarcoma cells ［J］.Medical Science Monitor,2018,24:3856-3862.
［22］SAKAMOTO W,TAKENOSHITA S.Overexpression of both clock and bmal1 inhibits entry to s phase in human colon cancer cells ［J］.Fukushima Journal of Medical Science,2015,61(2):111-124.
［23］WANG Y,QIAN R,SUN N,et al.Circadian gene hClock enhances proliferation and inhibits apoptosis of human colorectal carcinoma cells in vitro and in vivo ［J］.Molecular Medicine Reports,2015,11(6):4204-4210.
［24］TANG W,PENG W,ZHANG H,et al.Period 3,a tumor suppressor in non-small cell lung cancer,is silenced by hypermethylation ［J］.International Journal of Clinical and Experimental Pathology,2018,11(1):120-128.
［25］QIN T,LU XT,LI YG,et al.Effect of period 2 on the proliferation,apoptosis and migration of osteosarcoma cells,and the corresponding mechanisms ［J］.Oncology Letters,2018,16(2):2668-2674.
［26］OZTURK N,LEE JH,GADDAMEEDHI S,et al.Loss of cryptochrome reduces cancer risk in p53 mutant mice ［J］.Proceedings of the National Academy of Sciences of the United States of America,2009,106(8):2841-2846.
［27］JIANG W,ZHAO S,JIANG X,et al.The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway［J］.Cancer Letters,2016,371(2):314-325.
［28］ZHANFENG N,CHENGQUAN W,HECHUN X,et al.Period2 downregulation inhibits glioma cell apoptosis by activating the MDM2-TP53 pathway ［J］.Oncotarget,2016,7(19):27350-27362.
［29］HUBER AL,PAPP SJ,CHAN AB,et al.CRY2 and FBXL3 cooperatively degrade c-MYC ［J］.Molecular Cell,2016,64(4):774-789.
［30］SHOSTAK A,RUPPERT B,HA N,et al.MYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation ［J］.Nat Commun,2016,7:11807.
［31］ALTMAN BJ,HSIEH AL,SENGUPTA A,et al.MYC disrupts the circadian clock and metabolism in cancer cells［J］.Cell Metabolism,2015,22(6):1009-1019.
［32］GALLAGHER EJ,LEROITH D.Obesity and diabetes:the increased risk of cancer and cancer-related mortality［J］.Physiol Rev,2015,95(3):727-748.
［33］GUERRERO-VARGAS NN,NAVARRO-ESPINDOLA R,GUZMAN-RUIZ MA,et al.Circadian disruption promotes tumor growth by anabolic host metabolism;experimental evidence in a rat model ［J］.BMC Cancer,2017,17(1):625.
［34］KETTNER NM,VOICU H,FINEGOLD MJ,et al.Circadian homeostasis of liver metabolism suppresses hepatocarcinogenesis ［J］.Cancer Cell,2016,30(6):909-924.
［35］LIBERTI MV,LOCASALE JW.The Warburg effect:how does it benefit cancer cells［J］.Trends Biochem Sci,2016,41(3):211-218.
［36］PAPAGIANNAKOPOULOS T,BAUER MR,DAVIDSON SM,et al.Circadian rhythm disruption promotes lung tumorigenesis ［J］.Cell Metabolism,2016,24(2):324-331.
［37］YUAN P,YANG T,MU J,et al.Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells［J］.Cancer Letters,2020,469:498-509.
［38］FUHR L,EL-ATHMAN R,SCRIMA R,et al.The circadian clock regulates metabolic phenotype rewiring via HKDC1 and modulates tumor progression and drug response in colorectal cancer ［J］.EBioMedicine,2018,33:105-121.
［39］SHALAPOUR S,KARIN M.Immunity,inflammation,and cancer:an eternal fight between good and evil ［J］.The Journal of Clinical Investigation,2015,125(9):3347-3355.
［40］EARLY JO,MENON D,WYSE CA,et al.Circadian clock protein BMAL1 regulates IL-1beta in macrophages via NRF2 ［J］.Proceedings of the National Academy of Sciences of the United States of America,2018,115(36):E8460-E8468.
［41］NARASIMAMURTHY R,HATORI M,NAYAK SK,et al.Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines ［J］.Proceedings of the National Academy of Sciences of the United States of America,2012,109(31):12662-12667.
［42］GAJEWSKI TF,SCHREIBER H,FU YX.Innate and adaptive immune cells in the tumor microenvironment ［J］.Nat Immunol,2013,14(10):1014-1022.
［43］AIELLO I,FEDELE MLM,ROMAN F,et al.Circadian disruption promotes tumor-immune microenvironment remodeling favoring tumor cell proliferation ［J］.Science Advances,2020,6(42):eaaz4530.
［44］ZHOU L,LUO Z,LI Z,et al.Circadian clock is associated with tumor microenvironment in kidney renal clear cell carcinoma ［J］.Aging,2020,12(14):14620-14632.
［45］CHEN P,HSU WH,CHANG A,et al.Circadian regulator CLOCK recruits immune-suppressive microglia into the GBM tumor microenvironment ［J］.Cancer Discovery,2020,10(3):371-381.
［46］DE ASSIS LVM,KINKER GS,MORAES MN,et al.Expression of the circadian clock gene BMAL1 positively correlates with antitumor immunity and patient survival in metastatic melanoma ［J］.Front Oncol,2018,8:185.
［47］WU Y,TAO B,ZHANG T,et al.Pan-cancer analysis reveals disrupted circadian clock associates with T cell exhaustion ［J］.Frontiers in Immunology,2019,10:2451.
［48］LOGAN RW,ZHANG C,MURUGAN S,et al.Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats ［J］.J Immunol,2012,188(6):2583-2591.
［49］BALLESTA A,INNOMINATO PF,DALLMANN R,et al.Systems chronotherapeutics ［J］.Pharmacological Reviews,2017,69(2):161-199.
［50］GIACCHETTI S,BJARNASON G,GARUFI C,et al.Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil,leucovorin,and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer:the European Organisation for Research and Treatment of Cancer Chronotherapy Group ［J］.Journal of Clinical Oncology,2006,24(22):3562-3569.
［51］ROOSENDAAL J,JACOBS BAW,PLUIM D,et al.Phase I pharmacological study of continuous chronomodulated capecitabine treatment ［J］.Pharm Res,2020,37(5):89.
［52］PAWLIK TM,KEYOMARSI K.Role of cell cycle in mediating sensitivity to radiotherapy ［J］.International Journal of Radiation Oncology,Biology,Physics,2004,59(4):928-942.
［53］SHUKLA P,GUPTA D,BISHT SS,et al.Circadian variation in radiation-induced intestinal mucositis in patients with cervical carcinoma ［J］.Cancer,2010,116(8):2031-2035.
［54］RAHN DA,RAY DK,SCHLESINGER DJ,et al.Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer:is there a difference in outcome between morning and afternoon treatment［J］.Cancer,2011,117(2):414-420.
［55］SAPIENZA LG,NASRA K,BERRY R,et al.Clinical effects of morning and afternoon radiotherapy on high-grade gliomas ［J］.Chronobiology International,2021,38(5):732-741.